Cargando…
Development of Heterocyclic PPAR Ligands for Potential Therapeutic Applications
The family of nuclear peroxisome proliferator-activated receptors (PPARα, PPARβ/δ, and PPARγ) is a set of ligand-activated transcription factors that regulate different functions in the body. Whereas activation of PPARα is known to reduce the levels of circulating triglycerides and regulate energy h...
Autores principales: | Virendra, Sharma Arvind, Kumar, Ankur, Chawla, Pooja A., Mamidi, Narsimha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611956/ https://www.ncbi.nlm.nih.gov/pubmed/36297575 http://dx.doi.org/10.3390/pharmaceutics14102139 |
Ejemplares similares
-
Potential Therapeutic Effects of PPAR Ligands in Glioblastoma
por: Basilotta, Rossella, et al.
Publicado: (2022) -
Therapeutic potential of heterocyclic pyrimidine scaffolds
por: Kumar, Sanjiv, et al.
Publicado: (2018) -
Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic
por: Negi, Meenakshi, et al.
Publicado: (2020) -
PPAR-α Ligands as Potential Therapeutic Agents for Wet Age-Related Macular Degeneration
por: del V Cano, Marisol, et al.
Publicado: (2008) -
Natural Alkaloids and Heterocycles as G-Quadruplex Ligands and Potential Anticancer Agents
por: Che, Tong, et al.
Publicado: (2018)